新芝生物
(920685)
| 流通市值：7.03亿 | | | 总市值：11.72亿 |
| 流通股本：5490.39万 | | | 总股本：9151.60万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 34,891,531.29 | 169,724,864.23 | 114,171,509.27 | 71,149,555.52 |
| 营业收入 | 34,891,531.29 | 169,724,864.23 | 114,171,509.27 | 71,149,555.52 |
| 二、营业总成本 | 29,363,681.61 | 129,940,626.36 | 92,159,963.11 | 58,867,387.47 |
| 营业成本 | 13,003,912.84 | 62,457,166.53 | 42,583,622.74 | 26,694,563.99 |
| 税金及附加 | 416,161.95 | 2,188,803.36 | 1,661,784.89 | 1,061,638.04 |
| 销售费用 | 6,682,766.85 | 26,301,810.67 | 18,863,955.5 | 11,713,804.14 |
| 管理费用 | 5,019,862.49 | 21,310,569.02 | 16,470,640.77 | 11,428,371.85 |
| 研发费用 | 4,398,369.45 | 18,212,037.99 | 13,102,305.8 | 8,481,346.28 |
| 财务费用 | -157,391.97 | -529,761.21 | -522,346.59 | -512,336.83 |
| 其中:利息费用 | 63,957.34 | 167,619.5 | 128,067.12 | 83,611.51 |
| 其中:利息收入 | 442,004.84 | 882,333.02 | 694,504.68 | 553,886.56 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 834,471.86 | 3,377,216.92 | 2,425,059.92 | 1,598,663.34 |
| 加:投资收益 | 184,017.02 | 1,901,592.31 | 1,696,820.57 | 1,125,535.31 |
| 资产处置收益 | 0 | 145,904.27 | - | - |
| 资产减值损失(新) | -854,303.58 | -3,098,757.73 | -1,122,985.11 | -1,298,986.72 |
| 信用减值损失(新) | -48,749.6 | -475,840.75 | -238,534.63 | -77,260.5 |
| 其他收益 | 3,163,285.15 | 7,316,819.61 | 4,577,109.14 | 2,847,509.8 |
| 四、营业利润 | 8,806,570.53 | 48,951,172.5 | 29,349,016.05 | 16,477,629.28 |
| 加:营业外收入 | 13,278.26 | 65,678.03 | 35,654.02 | 45,254.81 |
| 减:营业外支出 | 7,630.08 | 351,354.24 | 55,662.02 | 13,543.67 |
| 五、利润总额 | 8,812,218.71 | 48,665,496.29 | 29,329,008.05 | 16,509,340.42 |
| 减:所得税费用 | 533,037.44 | 4,966,359.65 | 2,495,868.07 | 1,364,738.36 |
| 六、净利润 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 | 15,144,602.06 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 | 15,144,602.06 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 6,957,831.91 | 35,204,715.35 | 20,709,090.01 | 11,865,551.27 |
| 少数股东损益 | 1,321,349.36 | 8,494,421.29 | 6,124,049.97 | 3,279,050.79 |
| 扣除非经常损益后的净利润 | 4,785,518.62 | 29,070,801.85 | 15,530,837.13 | 8,928,793.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.4 | 0.23 | 0.13 |
| (二)稀释每股收益 | 0.08 | 0.4 | 0.23 | 0.13 |
| 九、综合收益总额 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 | 15,144,602.06 |
| 归属于母公司股东的综合收益总额 | 6,957,831.91 | 35,204,715.35 | 20,709,090.01 | 11,865,551.27 |
| 归属于少数股东的综合收益总额 | 1,321,349.36 | 8,494,421.29 | 6,124,049.97 | 3,279,050.79 |
| 公告日期 | 2026-04-27 | 2026-04-27 | 2025-10-29 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |